BMC Medical Ethics 11 (1):5- (2010)

Authors
Marie-Chantal Fortin
UNIVERSITE DE MONTREAL
Marianne Labrie
Université Laval
Abstract
BackgroundThe overwhelming scarcity of organs within renal transplantation forces researchers and transplantation teams to seek new ways to increase efficacy. One of the possibilities is the use of personalized medicine, an approach based on quantifiable and scientific factors that determine the global immunological risk of rejection for each patient. Although this approach can improve the efficacy of transplantations, it also poses a number of ethical questions.MethodsThe qualitative research involved 22 semi-structured interviews with nephrologists involved in renal transplantation, with the goal of determining the professionals' views about calculating the global immunological risk and the attendant ethical issues.ResultsThe results demonstrate a general acceptance of this approach amongst the participants in the study. Knowledge of each patient's immunological risk could improve treatment and the post-graft follow-up. On the other hand, the possibility that patients might be excluded from transplantation poses a significant ethical issue. This approach is not seen as something entirely new, given the fact that medicine is increasingly scientific and evidence-based. Although renal transplantation incorporates scientific data, these physicians believe that there should always be a place for clinical judgment and the physician-patient relationship.ConclusionsThe participants see the benefits of including the calculation of the global immunological risk within transplantation. Such data, being more precise and rigorous, could be of help in their clinical work. However, in spite of the use of such scientific data, a place must be retained for the clinical judgment that allows a physician to make decisions based on medical data, professional expertise and knowledge of the patient. To act in the best interests of the patient is key to whether the calculation of the global immunological risk is employed
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1186/1472-6939-11-5
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 69,959
Through your library

References found in this work BETA

Add more references

Citations of this work BETA

Add more citations

Similar books and articles

Promoting Patient Autonomy: Looking Back.Gene H. Stollerman - 1984 - Theoretical Medicine and Bioethics 5 (1).
The Clinical Ethicist at the Bedside.John Puma & David L. Schiedermayer - 1991 - Theoretical Medicine and Bioethics 12 (2).
Professional Autonomy in Belgium.Herman Nys & Paul Schotsmans - 2000 - Theoretical Medicine and Bioethics 21 (5):425-439.
The Concept of Medically Indicated Treatment.Franklin G. Miller - 1993 - Journal of Medicine and Philosophy 18 (1):91-98.
What is a Clinical Ethicist?Gregory T. Lyon-Loftus - 1986 - Theoretical Medicine and Bioethics 7 (1).
Ethical Issues in Family Medicine.Ronald J. Christie - 1986 - New York: Oxford University Press.
Markets in Health Care: The Case of Renal Transplantation.Troyen Brennan - 2007 - Journal of Law, Medicine and Ethics 35 (2):249-255.

Analytics

Added to PP index
2010-08-24

Total views
26 ( #438,695 of 2,504,809 )

Recent downloads (6 months)
1 ( #417,030 of 2,504,809 )

How can I increase my downloads?

Downloads

My notes